Effect of the ebna‐2 gene on the surface antigen phenotype of transfected ebv‐negative B‐lymphoma lines
- 15 January 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 45 (1) , 77-82
- https://doi.org/10.1002/ijc.2910450115
Abstract
Two EBV‐negative B‐lymphoma cell lines with different phenotypes were transfected with the Epstein‐Barr virus EBNA‐2 gene. The effects on the expression of 8 B‐cell surface markers were analyzed by immunofluorescence methods. In one of the EBNA‐2 transfected cell lines, the expression of the CR2 receptor CD21 was induced and the expression of CD23 was enhanced. The results suggest that the EBNA‐2 gene is involved in the regulation of CD21 and CD23 in EBV‐carrying cells.This publication has 43 references indexed in Scilit:
- The molecules controlling B lymphocytesImmunology Today, 1987
- Identification of Sequences in Epstein-Barr Virus DNA Required for the Expression of the Second Epstein-Barr Virus-determined Nuclear Antigen in COS-1 CellsJournal of General Virology, 1987
- Epstein‐Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphomaInternational Journal of Cancer, 1986
- Growth control of activated, synchronized murine B cells by the C3d fragment of human complementNature, 1985
- Chromosome mapping of cell membrane antigens expressed on activated B cellsEuropean Journal of Immunology, 1985
- Epstein-Barr virus susceptibility of normal human B lymphocyte populations.The Journal of Experimental Medicine, 1984
- Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.The Journal of Experimental Medicine, 1983
- A monoclonal antibody to human acute lymphoblastic leukaemia antigenNature, 1980
- Establishment and characteristics of two unique cell lines from patients with lymphosarcomaInternational Journal of Cancer, 1974
- A study of malignant tumours in Nigeria by short-term tissue cultureJournal of Clinical Pathology, 1965